Nahed El‐Najjar
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
-
- Nigella sativa pharmacological applications
- Natural Compounds in Disease Treatment
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 6
- Co-authors
- Hala Gali‐Muhtasib (7 shared papers)Regine Schneider‐Stock (3 shared papers)Heikki Vuorela (4 shared papers)André Gessner (9 shared papers)Matthias Ocker (2 shared papers)Raimo A. Ketola (3 shared papers)Arto Urtti (3 shared papers)Pia Vuorela (2 shared papers)
In The Last Decade
Nahed El‐Najjar
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 110
- Toxicology 304
- Complementary and alternative medicine 467
- Pharmacology 123
- Molecular Medicine 65
- Applied Microbiology and Biotechnology 15
Countries citing papers authored by Nahed El‐Najjar
This map shows the geographic impact of Nahed El‐Najjar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahed El‐Najjar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahed El‐Najjar more than expected).
Fields of papers citing papers by Nahed El‐Najjar
This network shows the impact of papers produced by Nahed El‐Najjar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahed El‐Najjar. The network helps show where Nahed El‐Najjar may publish in the future.
Co-authors
The 25 scholars most cited alongside Nahed El‐Najjar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 244 | |
| 2 | 2011 | 196 | |
| 3 | 2007 | 146 | |
| 4 | 2006 | 125 | |
| 5 | 2021 | 57 | |
| 6 | 2018 | 42 | |
| 7 | 2013 | 42 | |
| 8 | 2011 | 40 | |
| 9 | 2008 | 33 | |
| 10 | 2010 | 32 | |
| 11 | 2012 | 31 | |
| 12 | 2017 | 28 | |
| 13 | 2023 | 25 | |
| 14 | 2018 | 23 | |
| 15 | 2022 | 22 | |
| 16 | 2015 | 18 | |
| 17 | 2017 | 17 | |
| 18 | 2019 | 16 | |
| 19 | 2017 | 12 | |
| 20 | 2017 | 10 |
About Nahed El‐Najjar
Nahed El‐Najjar is a scholar working on Molecular Biology, Pharmacology, Complementary and alternative medicine, Epidemiology and Molecular Medicine, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Nigella sativa pharmacological applications (6 papers), Antibiotic Resistance in Bacteria (5 papers), Pneumonia and Respiratory Infections (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Urinary Tract Infections Management (2 papers) and Chemotherapy-induced organ toxicity mitigation (2 papers). The work is most often cited by research in Toxicology (304 citations), Complementary and alternative medicine (467 citations), Pharmacology (123 citations), Molecular Medicine (65 citations) and Applied Microbiology and Biotechnology (15 citations). Nahed El‐Najjar has collaborated with scholars based in Germany, Lebanon and Finland. Frequent co-authors include Hala Gali‐Muhtasib, Regine Schneider‐Stock, Heikki Vuorela, André Gessner, Matthias Ocker, Raimo A. Ketola, Arto Urtti, Pia Vuorela, Muktheshwar Gandesiri and Jonathan Jantsch. Their work appears in journals such as Oncology Reports, International Immunopharmacology, PLoS ONE, Cancers and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.